September 19 - 20, 2019

2nd Annual MarketsandMarkets Next Gen Immuno-Oncology Congress

Philadelphia - USA
45+
Speakers
250+
Attendees
7
Sessions

The next step towards changing treatment paradigms in immuno-oncology

The current revolution in immuno-oncology is being driven by Antibody Drug Conjugates, Immune Checkpoint Inhibitors, Bispecific Antibodies and Cell Therapies. Clinical trials have showed that cancer patients can tolerate this immune-based treatment more effectively than conventional treatments like chemotherapy and radiotherapy. It’s clearly one of the hottest fields of Biopharma which has gained momentum in the past few years.

users

With more than 45 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy  

users

Meet and network with experts from leading universities and industry sharing their knowledge on Preclinical and Translational Immuno-Oncology Developments, Next Gen CAR-T Cell Therapy, Immune Checkpoint Inhibitors, Monoclonal and Bispecific Antibodies and more.

users

A platform to meet experts from Pharma, bio-pharma and biotech companies and increase your learning in Monoclonal and Bispecific Antibodies, Cell Therapy and Immune Checkpoint Inhibitors.

After our successful edition last year, we are coming up with the “2nd Annual MarketsandMarkets Next-Gen Immuno-Oncology Congress” on 19-20 September, Philadelphia, USA which will gather academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in development of ADC’s, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.

WHAT TO EXPECT
Key Highlights
  • Updates in development of monoclonal Abs and bispecific Abs
  • Immune Checkpoint Inhibitors and Combinations
  • Preclinical and Translational Immuno-Oncology Developments
Sessions
  • Targeted Antibodies and Combinations
  • Pre-clinical & Translational Immuno-Oncology Developments
  • New Antibody Formats
  • New Immune Checkpoints for Immunotherapy
Why Attend
  • Find out new case studies of antibody projects in development
  • Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you
CONFERENCE SPEAKERS
Advisors
Rakesh Dixit

Rakesh Dixit

CEO
Bionavigen

Rakesh Dixit

CEO
Bionavigen
Stefan Glueck

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene
Speakers
Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets

Shailendra Singh (Shelly)

Chief Operating Officer
MarketsandMarkets
Rakesh Dixit

Rakesh Dixit

CEO
Bionavigen

Rakesh Dixit

CEO
Bionavigen
Roy Baynes

Roy Baynes

Senior Vice President
Merck

Roy Baynes

Senior Vice President
Merck
Stefan Glueck

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene

Stefan Glueck

Senior Vice President, Global Medical Affairs
Celgene
Shahram Salek-Ardakani

Shahram Salek-Ardakani

Senior Director, Cancer Immunology
Pfizer

Shahram Salek-Ardakani

Senior Director, Cancer Immunology
Pfizer
Joost Oppenheim

Joost Oppenheim

Head, Cellular Immunology
NIH

Joost Oppenheim

Head, Cellular Immunology
NIH
Carl Morrison

Carl Morrison

President, Chief Medical Officer
OmniSeq

Carl Morrison

President, Chief Medical Officer
OmniSeq
Scott Durum

Scott Durum

Head, Cytokines and Immunity
NIH

Scott Durum

Head, Cytokines and Immunity
NIH
David Szymkowski

David Szymkowski

Vice President, Cell Biology
Xencor

David Szymkowski

Vice President, Cell Biology
Xencor
Li Peng

Li Peng

Senior Vice President
Palleon Pharma

Li Peng

Senior Vice President
Palleon Pharma
Sebastien Tabruyn

Sebastien Tabruyn

Chief Scientific Officer
Transcure Bioservices

Sebastien Tabruyn

Chief Scientific Officer
Transcure Bioservices
Natalie Russi

Natalie Russi

Scientific Project Manager
Nebion

Natalie Russi

Scientific Project Manager
Nebion
SPONSORS
Gold Sponsors
example-image

BIOCYTOGEN

Sponsors & Exhibitors
example-image

Myriad RBM

example-image

TransCure bioServices

example-image

Nebion

example-image

Flagship Biosciences

PARTNERS
Supporting Association
example-image

BioPartner UK

Media Partners
example-image

SciDoc Publishers

example-image

Technology Networks

example-image

GEN

example-image

PharmaTutor

example-image

PharmaVOICE

LOCATION
Philadelphia - USA

Please contact us on events@marketsandmarkets.com to get hotel booking link.

About the Hotel

For any queries regarding the hotel booking please write to us at events@marketsandmarkets.com

Hotel Booking Link

You will receive a link to book your accommodation via email once you are fully registered. (Please note that we do not authorize any 3rd party agencies (e.g. Exhibitors Housing Management) to book on our behalf and, occasionally, companies fraudulently try to represent us. If you are contacted by anyone other than us regarding your accommodation requirements for this event, please let us know immediately on events@marketsandmarkets.com

PAST EVENT GALLERY